Macrophage-specific expression of urokinase-type plasminogen activator promotes skeletal muscle regeneration

Journal of Immunology

Volumn 187, Issue 3, 2011, Pages 1448-1457

  Novak, Margaret L ^a   Bryer, Scott C ^a   Cheng, Ming ^a   Nguyen, Mai Huong ^a   Conley, Kevin L ^a   Cunningham, Andrew K ^b   Xue, Bing ^b   Sisson, Thomas H ^b   You, Jae Sung ^c   Hornberger, Troy A ^c   Koh, Timothy J ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SCATTER FACTOR; UROKINASE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; FEMALE; MACROPHAGE; MALE; MOUSE; MUSCLE CELL; MUSCLE INJURY; MUSCLE REGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REGULATORY MECHANISM; SKELETAL MUSCLE; TISSUE REPAIR; TRANSGENIC MOUSE; WILD TYPE;

ANIMALS; CELL LINE; CELL MOVEMENT; CELLS, CULTURED; FEMALE; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MUSCLE DEVELOPMENT; MUSCLE, SKELETAL; NEOVASCULARIZATION, PHYSIOLOGIC; REGENERATION; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 80051651442     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1004091     Document Type: Article

References (46)

1. Arnold, L., A. Henry, F. Poron, Y. Baba-Amer, N. van Rooijen, A. Plonquet, R. K. Gherardi, and B. Chazaud. 2007. Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J. Exp. Med. 204: 1057-1069. (Pubitemid 46798150)
2. Lambert, J. M., E. F. Lopez, and M. L. Lindsey. 2008. Macrophage roles following myocardial infarction. Int. J. Cardiol. 130: 147-158.
3. Mirza, R., L. A. DiPietro, and T. J. Koh. 2009. Selective and specific macro-phage ablation is detrimental to wound healing in mice. Am. J. Pathol. 175: 2454-2462.
4. Ricardo, S. D., H. van Goor, and A. A. Eddy. 2008. Macrophage diversity in renal injury and repair. J. Clin. Invest. 118: 3522-3530.
5. Koh, T. J., S. C. Bryer, A. M. Pucci, and T. H. Sisson. 2005. Mice deficient in plasminogen activator inhibitor-1 have improved skeletal muscle regeneration. Am. J. Physiol. Cell Physiol. 289: C217-C223. (Pubitemid 40880842)
6. Shimizu, M., A. Hara, M. Okuno, H. Matsuno, K. Okada, S. Ueshima, O. Matsuo, M. Niwa, K. Akita, Y. Yamada, et al. 2001. Mechanism of retarded liver regeneration in plasminogen activator-deficient mice: impaired activation of hepatocyte growth factor after Fas-mediated massive hepatic apoptosis. Hepatology 33: 569-576. (Pubitemid 32185218)
7. Swaisgood, C. M., E. L. French, C. Noga, R. H. Simon, and V. A. Ploplis. 2000. The development of bleomycin-induced pulmonary fibrosis in mice deficient for components of the fibrinolytic system. Am. J. Pathol. 157: 177-187. (Pubitemid 30641735)
8. Sisson, T. H., K. E. Hanson, N. Subbotina, A. Patwardhan, N. Hattori, and R. H. Simon. 2002. Inducible lung-specific urokinase expression reduces fibrosis and mortality after lung injury in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 283: L1023-L1032. (Pubitemid 35204894)
9. Lluís, F., J. Roma, M. Suelves, M. Parra, G. Aniorte, E. Gallardo, I. Illa, L. Rodríguez, S. M. Hughes, P. Carmeliet, et al. 2001. Urokinase-dependent plasminogen activation is required for efficient skeletal muscle regeneration in vivo. Blood 97: 1703-1711. (Pubitemid 32217237)
10. Sisson, T. H., M. H. Nguyen, B. Yu, M. L. Novak, R. H. Simon, and T. J. Koh. 2009. Urokinase-type plasminogen activator increases hepatocyte growth factor activity required for skeletal muscle regeneration. Blood 114: 5052-5061.
11. Bryer, S. C., G. Fantuzzi, N. Van Rooijen, and T. J. Koh. 2008. Urokinase-type plasminogen activator plays essential roles in macrophage chemotaxis and skeletal muscle regeneration. J. Immunol. 180: 1179-1188.
12. Duffy, M. J. 2004. The urokinase plasminogen activator system: role in malignancy. Curr. Pharm. Des. 10: 39-49. (Pubitemid 38072742)
13. Das, A., and P. McGuire. 2006. Role of urokinase inhibitors in choroidal neovascularization. Semin. Ophthalmol. 21: 23-27. (Pubitemid 43879511)
14. Binder, B. R., J. Mihaly, and G. W. Prager. 2007. uPAR-uPA-PAI-1 interactions and signaling: a vascular biologist's view. Thromb. Haemost. 97: 336-342. (Pubitemid 46437793)
15. Suelves, M., B. Vidal, A. L. Serrano, M. Tjwa, J. Roma, R. López-Alemany, A. Luttun, M. M. de Lagrán, A. Díaz-Ramos, M. Jardí, et al. 2007. uPA deficiency exacerbates muscular dystrophy in MDX mice. J. Cell Biol. 178: 1039-1051. (Pubitemid 47443325)
16. Mars, W. M., R. Zarnegar, and G. K. Michalopoulos. 1993. Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA. Am. J. Pathol. 143: 949-958. (Pubitemid 24058250)
17. Naldini, L., E. Vigna, A. Bardelli, A. Follenzi, F. Galimi, and P. M. Comoglio. 1995. Biological activation of pro-HGF (hepatocyte growth factor) by urokinase is controlled by a stoichiometric reaction. J. Biol. Chem. 270: 603-611.
18. Galimi, F., E. Cottone, E. Vigna, N. Arena, C. Boccaccio, S. Giordano, L. Naldini, and P. M. Comoglio. 2001. Hepatocyte growth factor is a regulator of monocyte-macrophage function. J. Immunol. 166: 1241-1247. (Pubitemid 32060285)
19. Odekon, L. E., Y. Sato, and D. B. Rifkin. 1992. Urokinase-type plasminogen activator mediates basic fibroblast growth factor-induced bovine endothelial cell migration independent of its proteolytic activity. J. Cell. Physiol. 150: 258-263.
20. Okada, S. S., S. R. Grobmyer, and E. S. Barnathan. 1996. Contrasting effects of plasminogen activators, urokinase receptor, and LDL receptor-related protein on smooth muscle cell migration and invasion. Arterioscler. Thromb. Vasc. Biol. 16: 1269-1276. (Pubitemid 26339715)
21. Traktuev, D. O., Z. I. Tsokolaeva, A. A. Shevelev, K. A. Talitskiy, V. V. Stepanova, B. H. Johnstone, T. M. Rahmat-Zade, A. N. Kapustin, V. A. Tkachuk, K. L. March, and Y. V. Parfyonova. 2007. Urokinase gene transfer augments angiogenesis in ischemic skeletal and myocardial muscle. Mol. Ther. 15: 1939-1946. (Pubitemid 350011733)
22. Deindl, E., T. Ziegelhöffer, S. M. Kanse, B. Fernandez, E. Neubauer, P. Carmeliet, K. T. Preissner, and W. Schaper. 2003. Receptor-independent role of the urokinase-type plasminogen activator during arteriogenesis. FASEB J. 17: 1174-1176.
23. Cozen, A. E., H. Moriwaki, M. Kremen, M. B. DeYoung, H. L. Dichek, K. I. Slezicki, S. G. Young, M. Véniant, and D. A. Dichek. 2004. Macrophagetargeted overexpression of urokinase causes accelerated atherosclerosis, coronary artery occlusions, and premature death. Circulation 109: 2129-2135. (Pubitemid 38620223)
24. Moriwaki, H., A. Stempien-Otero, M. Kremen, A. E. Cozen, and D. A. Dichek. 2004. Overexpression of urokinase by macrophages or deficiency of plasminogen activator inhibitor type 1 causes cardiac fibrosis in mice. Circ. Res. 95: 637-644. (Pubitemid 39274379)
25. -/-mice. Arterioscler. Thromb. Vasc. Biol. 29: 1737-1744.
26. Bryer, S. C., and T. J. Koh. 2007. The urokinase-type plasminogen activator receptor is not required for skeletal muscle inflammation or regeneration. Am. J. Physiol. Regul. Integr. Comp. Physiol. 293: R1152-R1158. (Pubitemid 47358936)
27. Arras, M., W. D. Ito, D. Scholz, B. Winkler, J. Schaper, and W. Schaper. 1998. Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. J. Clin. Invest. 101: 40-50. (Pubitemid 28058901)
28. Lin, E. Y., J. F. Li, L. Gnatovskiy, Y. Deng, L. Zhu, D. A. Grzesik, H. Qian, X. N. Xue, and J. W. Pollard. 2006. Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res. 66: 11238-11246. (Pubitemid 46009952)
29. Buchstein, N., D. Hoffmann, H. Smola, S. Lang, M. Paulsson, C. Niemann, T. Krieg, and S. A. Eming. 2009. Alternative proteolytic processing of hepatocyte growth factor during wound repair. Am. J. Pathol. 174: 2116-2128.
30. Halevy, O., and L. C. Cantley. 2004. Differential regulation of the phosphoinositide 3-kinase and MAP kinase pathways by hepatocyte growth factor vs. insulin-like growth factor-I in myogenic cells. Exp. Cell Res. 297: 224-234. (Pubitemid 38759575)
31. Taipale, J., and J. Keski-Oja. 1997. Growth factors in the extracellular matrix. FASEB J. 11: 51-59. (Pubitemid 27076324)
32. Matsuoka, H., T. H. Sisson, T. Nishiuma, and R. H. Simon. 2006. Plasminogenmediated activation and release of hepatocyte growth factor from extracellular matrix. Am. J. Respir. Cell Mol. Biol. 35: 705-713. (Pubitemid 44901860)
33. Allen, R. E., S. M. Sheehan, R. G. Taylor, T. L. Kendall, and G. M. Rice. 1995. Hepatocyte growth factor activates quiescent skeletal muscle satellite cells in vitro. J. Cell. Physiol. 165: 307-312.
34. Tatsumi, R., J. E. Anderson, C. J. Nevoret, O. Halevy, and R. E. Allen. 1998. HGF/SF is present in normal adult skeletal muscle and is capable of activating satellite cells. Dev. Biol. 194: 114-128. (Pubitemid 28115263)
35. van Amerongen, M. J., M. C. Harmsen, N. van Rooijen, A. H. Petersen, and M. J. van Luyn. 2007. Macrophage depletion impairs wound healing and increases left ventricular remodeling after myocardial injury in mice. Am. J. Pathol. 170: 818-829.
36. Jayasankar, V., Y. J. Woo, L. T. Bish, T. J. Pirolli, S. Chatterjee, M. F. Berry, J. Burdick, T. J. Gardner, and H. L. Sweeney. 2003. Gene transfer of hepatocyte growth factor attenuates postinfarction heart failure. Circulation 108(Suppl. 1): II230-II236. (Pubitemid 37099960)
37. Conway, K., P. Price, K. G. Harding, and W. G. Jiang. 2006. The molecular and clinical impact of hepatocyte growth factor, its receptor, activators, and inhibitors in wound healing. Wound Repair Regen. 14: 2-10.
38. Bevan, D., E. Gherardi, T. P. Fan, D. Edwards, and R. Warn. 2004. Diverse and potent activities of HGF/SF in skin wound repair. J. Pathol. 203: 831-838. (Pubitemid 38961570)
39. Brand-Saberi, B., T. S. Müller, J. Wilting, B. Christ, and C. Birchmeier. 1996. Scatter factor/hepatocyte growth factor (SF/HGF) induces emigration of myogenic cells at interlimb level in vivo. Dev. Biol. 179: 303-308. (Pubitemid 26363266)
40. Bussolino, F., M. F. Di Renzo, M. Ziche, E. Bocchietto, M. Olivero, L. Naldini, G. Gaudino, L. Tamagnone, A. Coffer, and P. M. Comoglio. 1992. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J. Cell Biol. 119: 629-641.
41. Kobayashi, H., L. M. DeBusk, Y. O. Babichev, D. J. Dumont, and P. C. Lin. 2006. Hepatocyte growth factor mediates angiopoietin-induced smooth muscle cell recruitment. Blood 108: 1260-1266. (Pubitemid 44232023)
42. Fuhrman, B., O. Nitzan, R. Karry, N. Volkova, I. Dumler, and M. Aviram. 2007. Urokinase plasminogen activator (uPA) stimulates cholesterol biosynthesis in macrophages through activation of SREBP-1 in a PI3-kinase and MEK-dependent manner. Atherosclerosis 195: e108-e116. (Pubitemid 350087988)
43. Mukhina, S., V. Stepanova, D. Traktouev, A. Poliakov, R. Beabealashvilly, Y. Gursky, M. Minashkin, A. Shevelev, and V. Tkachuk. 2000. The chemotactic action of urokinase on smooth muscle cells is dependent on its kringle domain: characterization of interactions and contribution to chemotaxis. J. Biol. Chem. 275: 16450-16458. (Pubitemid 30398865)
44. Kuramoto, E., T. Nishiuma, K. Kobayashi, M. Yamamoto, Y. Kono, Y. Funada, Y. Kotani, T. H. Sisson, R. H. Simon, and Y. Nishimura. 2009. Inhalation of urokinase-type plasminogen activator reduces airway remodeling in a murine asthma model. Am. J. Physiol. Lung Cell. Mol. Physiol. 296: L337-L346.
45. Lin, Y., W. F. Xie, Y. X. Chen, X. Zhang, X. Zeng, H. Qiang, W. Z. Chen, X. J. Yang, Z. G. Han, and Z. B. Zhang. 2005. Treatment of experimental hepatic fibrosis by combinational delivery of urokinase-type plasminogen activator and hepatocyte growth factor genes. Liver Int. 25: 796-807. (Pubitemid 41038661)
46. Horvai, A., W. Palinski, H. Wu, K. S. Moulton, K. Kalla, and C. K. Glass. 1995. Scavenger receptor A gene regulatory elements target gene expression to macrophages and to foam cells of atherosclerotic lesions. Proc. Natl. Acad. Sci. USA 92: 5391-5395.